EDIT vs ENPH · rev $32.3M vs P/E 56, rev $1.47B
Editas Medicine Inc (EDIT) versus Enphase Energy Inc (ENPH) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Enphase Energy Inc (ENPH) is a solar company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported ENPH revenue for 2025-12-31 was $1.47B. Net income was $172.1M. Revenue was up 10.7% from 2024-12-31 to 2025-12-31. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
EDIT currently screens at market cap $375.2M. ENPH currently screens at market cap $7.39B and trailing P/E 55.5.
Not investment advice. Open the EDIT and ENPH stock pages for the full models.
Not investment advice.